Participants with serious adverse reactions · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Physical functioning End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression Measured at end of treatment, 26 weeks · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Depression Long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Sleep · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Physical functioning End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Physical functioning component of health‐related quality of life, measured using various scales · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
2 findings from 1 review
Resolution or improvement of telangiectasias ( · people with telangiectasias and reticular veins
1 finding from 1 review
Adverse events ‐ hyperpigmentation ( · people with telangiectasias and reticular veins
Laser plus sclerotherapy showed no clear difference in adverse events ‐ Hyperpigmentation ( compared with sclerotherapy (low certainty).
1 finding from 1 review
Adverse events ‐ matting ( · people with telangiectasias and reticular veins
Laser plus sclerotherapy showed no clear difference in adverse events ‐ matting ( compared with sclerotherapy (low certainty).
1 finding from 1 review
Pain ( · people with telangiectasias and reticular veins
Laser plus sclerotherapy may leads to higher pain ( compared with sclerotherapy (low certainty).
1 finding from 1 review
Recurrence · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to resolution · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · DCM (non‐ischaemic)
It is very uncertain whether stem cell therapy changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
Procedural complications · DCM (non‐ischaemic)
1 finding from 1 review